DNA Script

DNA Script

DNA Script is a DNA synthesis company founded by Thomas Ybert, Sylvain Gariel, and Xavier Gordon in 2014, and headquartered in Paris, France.

DNA Script produces synthetic DNA using enzymatic synthesis for use in drug discovery, industrial biotechnology, food technology, and nanotechnologies. The company is headquartered in Paris, France and was founded in 2014 by Thomas Ybert, Sylvain Gariel, and Xavier Gordon.

Funding

European Commission and Bpifrance grant

In April 2018, DNA Script announced that it has been awarded $5.5 million in grant funding from the European Commission and French investment bank Bpifrance.

Series A

In September 2017, DNA Script closed their Series A round. It was led by Illumina Ventures and joined by Merck Ventures and existing investors Sofinnova Partners, Kurma Partners, and Idinvest Partners. In total they raised a total of €11M.

Timeline

September 2017

DNA Script raises a $13,100,000 series A round from Sofinnova Partners, M Ventures, Illumina Ventures, IDInvest Partners and Kurma Partners.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Elise Champion

Director Research

Sylvain Gariel

Co-Founder & COO

Thomas Ybert

Co-Founder & CEO

Xavier Gordon

Co-Founder & CTO

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.